from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2768c/PPE43

LFCtreatmentdescriptionclass of inhibitor

0.877

Amikacinug/mL Amikacintranslation

0.078

Cap5-10ug/mL Capreomycintranslation

0.782

Rox10-50 ug/mL Roxithromycintranslation

-0.334

SM2-5 ug/mL Streptomycintranslation

1.665

Tet5-10 ug/mL Tetracyclinetranslation

1.187

Rif0.2-5ug/mL Rifampicintranscription

-0.425

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.102

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.265

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.861

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.420

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.302

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.207

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.646

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.192

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.619

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.054

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.927

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.749

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-2.022

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.798

KCN5-20 ug/mL Potassium cyaniderespiration

-0.750

NaN30.2-2 mM Sodium aziderespiration

-1.530

Nigericin50 uM Nigericinrespiration

-0.457

TRC10-150 ug/mL Triclosanrespiration

-0.747

TRZ10-25 ug/mL Thioridazinerespiration

0.793

Valinomycin0.5-10 uM Valinomycinrespiration

-0.055

ZnSO42 mM ZnSO4respiration

-1.366

menadione6-10 ug/mL Menadionerespiration

0.063

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.424

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.144

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.491

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.033

NRP_1Non-replicating persistence stage 1dosRassociated

-0.082

Amp0.2mg/mL AmpicillincellWall

0.314

Cephalexin20-100 ug/mL CephalexincellWall

-0.502

Cerulenin0.32-5 ug/mL CerulenincellWall

0.544

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.690

EMB10-20 ug/mL EthambutolcellWall

-0.592

Eta12-40 ug/mL EthionamidecellWall

-0.404

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.029

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.453

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.108

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.004

BZA0.12 mg/mL BenzamidearomaticAmides

0.431

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.607

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.367

H2O24 mM hydrogen peroxideDNAdamaging

-0.256

Levo10 ug/mL LevofloxacinDNAdamaging

0.607

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.549

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.212

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.168

UVUV-irradiationDNAdamaging

1.012

ARP41-4 ug/mL Antitubercular compound ARP4?

0.309

Antimycin12.5-50 ug/mL Antimycin A?

-1.260

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.946

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.447

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.871

PA8240.2-2 ug/mL PA-824?

0.230

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.198

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.246

Verapamil50 uM Verapamil?

-1.346

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.417

methoxatin10-20 ug/mL Methoxatin?